INTRODUCTION
Benign periarticular, bone and joint lipomatous lesions affect people of a wide range of ages -from the late paediatric to the geriatric populations, with an average age of 40-60 years. (1) (2) (3) (4) (5) These lesions are rare and tend to have either an equal maleto-female distribution or a slight male preponderance. (1, 3) With the advent of advanced imaging modalities, benign lesions are increasingly being characterised. Thus, it is important to recognise their imaging features, so as to avoid unnecessary biopsies. In this review, we outline the clinical presentations of benign periarticular, bone and joint lipomatous lesions and illustrate their distinctive imaging features.
INTRAOSSEOUS LIPOMA
Intraosseous lipoma is a rare, benign bone lesion with a cited prevalence of less than 0.1% of bone tumours reported. (1, 6) The true prevalence in the general population may be higher, as this lesion is commonly asymptomatic and its radiographic features may lead to it being labelled as benign without further characterisation. Pathologic interpretation of this lesion in the absence of radiological correlation may sometimes be misleading, as histologically, an intraosseous lipoma can be difficult to differentiate from normal fat in yellow marrow or from osteonecrosis. (1) There is a slight male preponderance, with one meta-analysis reporting a male-to-female ratio of 4:3.
(2) There is a wide age range at first presentation (5-85 years), with the majority affected in their fourth to fifth decades of life. (1, 2) Clinically, approximately half of the patients with intraosseous lipoma are asymptomatic. (7) Symptomatic patients may present with pain, which has been hypothesised to be due to expansile remodelling of the bone or the related ischaemic changes that accompany such lesions; alternatively, the pain may be purely incidental, such as when the pain trigger arises from a nearby pathology.
(1) Swelling and pathological fractures are rare clinical presentations. (1, 2) Commonly affected sites include: the calcaneum (8%) (Figs. 1-3) ; intertrochanteric or subtrochanteric regions of the femur (34%) (Fig. 4) ; proximal tibial metaphysis (13%) (Fig. 5) ; pelvis (8%) (Fig. 6) ; and the spine (Fig. 7) include: the proximal and distal fibular metaphyses; humerus (Fig. 8) ; skull; mandible; rib; and radius.
(1,2) Intraosseous lipoma can extend from the metaphysis to the diaphysis or epiphysis, although the epiphysis is an uncommon site. (1, 2) A key imaging feature of intraosseous lipoma is the presence of fat, which has radiological characteristics that are similar to subcutaneous fat on all modalities. Hence, radiographically, the lesion typically appears radiolucent (Fig. 1) .
(1,2,6) On computed tomography (CT), it has a fat density of −60 HU to −100 HU (1) and shows resorption of bone trabeculae. (1, 6) Magnetic resonance (MR) imaging shows the lesion to be isointense to subcutaneous fat on T1-and T2-weighted images, and hypointense on fat-saturated sequences. Compared to the surrounding normal bone marrow, the lesion has mildly higher T1-weighted signal intensity. In addition, a thin hypointense rim due to capsular or peripheral ossification may be present. (1, 6) Although rare, expansile remodelling of the bone (Fig. 6 ), which has been described in the fibula, spine and sacrum, is also a useful feature. (2) Milgram describes three types of intraosseous lipoma: Stage 1 lesions consist of only viable fat cells (Fig. 1) ; Stage 2 lesions contain viable fat cells as well as fat necrosis and calcification (Fig. 2) ; and Stage 3 lesions have necrotic fat, calcification of necrotic fat, cysts and reactive woven bone (Fig. 3) . (7) The radiological findings of the various stages reflect that of their histological components. The imaging features of the lipomatous component of these lesions have been described earlier. Fat necrosis, which is seen in Stage 2 and 3 lesions, is hyperdense on CT.
(7) On MR imaging, fat necrosis has variable T1-weighted signal and is hyperintense on T2-weighted images. (6) Cystic formations are hypointense on T1-weighted images and hyperintense on T2-weighted images. Calcifications within the central portion of Stage 2 and 3 intraosseous lipomas appear as signal voids on MR imaging. Haemorrhage, which is exceedingly rare, is hyperintense on T1-weighted images with or without fatsaturation and hypointense on T2-weighted images. (8) On bone scintigraphy, intraosseous lipomas demonstrate absent-to-moderate uptake of radionuclide (Fig. 6b) . (9) Intraosseous lipoma of the calcaneum has a classical appearance. It usually occurs at the critical angle of the calcaneum, which is an area of increased porosity that is physiological. Compared to intraosseous lipomas at other sites, calcaneal lipomas show a greater prevalence of marginal sclerosis (61%) and internal calcification (62%), and rarely cause bone expansion.
(2) Calcification within a lucent lesion at the critical angle of the calcaneum, which is pathognomonic of intraosseous lipoma, helps to differentiate it from unicameral bone cysts. (1) Differentiating intraosseous lipoma from osteonecrosis on CT and MR imaging may be difficult at times, as they both contain fat and are separated from the surrounding marrow by a rim of tissue. (1) Distinguishing features of intraosseous lipoma include resorption of bone trabeculae, a rounded (rather than serpentine) margin and expansile remodelling. (1, 6) Radiographically, intraosseous lipoma may be mistaken for fibrous dysplasia. However, fibrous dysplasia is hypointense on T1-weighted images and demonstrates heterogeneous enhancement, and its epicentre is often at the diaphysis. Other differential diagnoses include osteoblastoma, enchondroma, chondroblastoma, chondrosarcoma, Brodie abscess, non-ossifying fibroma and giant cell tumour. (7) Intraosseous lipomas are usually solitary lesions, although multiple lesions have been described. (2) It is important to distinguish them from multiple lipomatosis, which, unlike intraosseous lipoma, is not encapsulated by connective tissue and may be due to endocrinological abnormalities such as Type IV hyperlipoproteinaemia. (10) A conservative approach to the management of asymptomatic or incidentally discovered intraosseous lipomas is often taken. Symptomatic lesions have been treated successfully with curettage and bone graft placement.
(7) They rarely recur after treatment and malignant transformation is uncommon.
(1)
LIPOSCLEROSING MYXOFIBROUS TUMOUR
Liposclerosing myxofibrous tumour (LSMFT) is a benign fibroosseous lesion that consists of a wide range of histological components, including myxoid change, lipoma, fat necrosis, fibroxanthoma, fibrosis, reactive bone, ischaemic ossification, calcification and fibrous dysplasia-like features. (1, 3, 4) The origin of LSMFT is contentious. Some authors regard LSMFT as a manifestation of an underlying well-known bone entity with varying degrees of degeneration. Histological and genetic studies suggest that the underlying bone entity may be fibrous dysplasia or intraosseous lipoma. (4) Others, however, consider it a distinct entity.
LSMFT affects an equal proportion of men and women. The age of presentation ranges from 15 to 80 years. (3, 4) In Kransdorf et al's study, 85% of the lesions occurred in the femur, with 91% of these being located at the intertrochanteric region (Fig. 9) . Other uncommon sites include the femoral shaft, ilium, humerus and rib. (3) LSMFT is often asymptomatic or may present with pain. Occasionally, patients may present with pathological fractures. (3) Radiographically, LSMFT has a geographic lucent appearance with a sclerotic margin, in the presence or absence of expansile remodelling. (1, 3, 4) Mineralised matrix is often present. On bone scintigraphy, it has increased radionuclide uptake, but to a lesser degree than in fibrous dysplasia.
(1,3) Interestingly, despite the presence of lipomatous tissue (however small the amount), the lesion does not have lipomatous characteristics on CT or MR imaging, likely because the lipomatous tissue has intermixed with myxofibrous or fibro-osseous tissue.
(1) On CT, its non-mineralised regions have a higher density than fat, but a lower density than skeletal muscle. On MR imaging, it is moderately homogeneous, and appears isointense to skeletal muscle on T1-weighted images and hyperintense on T2-weighted images.
(3) Differential diagnoses of LSMFT include intraosseous lipoma and fibrous dysplasia. Malignant transformation has been described in 10%-16% of cases, the majority of which are osteosarcomas. (1, 3) Other malignancies that LSMFT can transform into include malignant fibrous histiocytoma, (1, 3) malignant fibroxanthomas and high-grade spindle cell tumours.
Treatment of LSMFT depends on its presentation. Asymptomatic lesions that are discovered incidentally may not warrant treatment, while symptomatic lesions may be treated with curettage, bone grafting and fixation.
(1) A high level of suspicion for malignancy should be maintained if the lesion has aggressive features or recurs quickly after surgical resection.
LIPOMA ARBORESCENS
Lipoma arborescens is a rare intra-or extra-articular (5, 11) benign lesion with villous synovial proliferation and subsynovial replacement of fat. It affects patients across a wide age range (15-90 years) (5) with an average age of 50 years. (5, 11) The gender distribution of affected patients is almost equal. (5) Patients may present clinically with stiffness, swelling or pain. (11) In a study by Howe and Wenger, (5) 72% of cases of lipoma arborescens were cases of monoarticular involvement of the knee (Fig. 10) . Other sites of involvement included the shoulder (Fig. 11) ; the elbow or bicipitoradial bursa (Fig. 12) ; extensor compartment of the wrist; the hip; and the ankle.
(5) Polyarticular involvement is rare. These lesions are often associated with degenerative or inflammatory arthritis. (5, 11) Lesions that involve the shoulder are associated with rotator cuff tears. (5) Most cases of lipoma arborescens are diffuse, although onefifth of them present as pseudomasses.
(11) Radiographically, soft tissue swelling in the joint may be detected. (12) On CT, the soft tissue lesion appears as fat attenuation. Its villous appearance on CT may not be as well appreciated as it would be on MR imaging. On MR imaging, the key imaging feature is the presence of a frond-like synovial lesion with high signal intensity on T1-and T2-weighted images, similar to subcutaneous fat, (12) which is suppressed on fat-saturated or short tau inversion recovery sequences (Figs. 10-12) . (11) (12) (13) The lesion does not enhance in the postcontrast phase (13) and may produce a chemical shift artefact at the fat-fluid interface on gradient echo sequences. (12) Lipoma arborescens is often associated with an effusion (Figs. 10-12 ).
There are several differential diagnoses. One of them is synovial lipoma, which usually presents as a round or oval mass-like lesion. In the knee, synovial lipoma tends to affect the infrapatellar fat pad rather than the suprapatellar bursa; the latter is often affected in lipoma arborescens. (11, 12) Pigmented villonodular synovitis, another differential diagnosis, contains haemosiderin, which shows a diffuse, low signal on T1-and T2-weighted images, and susceptibility on gradient echo sequences. Furthermore, it enhances in the postcontrast phase. (12) Haemangiomas show intermediate signal on T1-and T2-weighted images, and may contain signal voids or hypointense septa. Pannus in rheumatoid arthritis has intermediate to low signal on T1-and T2-weighted images. (13) The typical treatment for lipoma arborescens is arthroscopic or open synovectomy. (1, 12) 
INTRA-ARTICULAR LIPOMA
Discrete intra-articular (synovial) lipoma is a very rare lesion with approximately 24 cases reported to date. (14) Most of them occurred in the knee (n = 19), while one case each was reported in the following joints: hip, (15) lumbar facet, tarsometatarsal, elbow and shoulder. (1, 14, 16, 17) The case of shoulder intra-articular lipoma featured in this article may be the first published case that demonstrates its MR imaging appearance in the shoulder joint (Fig. 13) .
The clinical presentation of intra-articular lipoma depends on the site and size of the lesion. Patients may be asymptomatic or have complaints of dull pain due to pressure, a sudden pain related to twisting and strangulation of the lipoma, limitation of motion, crepitus and joint effusion. (14, 16) Intra-articular lipoma may not always be identified on radiographs, especially when it is small. (15, 16) If visualised, the lesion presents as a well-defined radiolucency. (14) MR imaging is the next imaging modality for investigation of this lesion. On MR imaging, the lesion is hyperintense on both T1-and T2-weighted sequences (Fig. 13) . (16) However, it can also present as a nonspecific finding on MR imaging, appearing heterogeneous with fluid-like signal within that is thought to be due to mucoid degeneration. (1, 14) The main differential diagnosis is lipoma arborescens, (14, 16) which is also an intra-articular lipomatous lesion. An important characteristic that differentiates the two types of lesions is the villous appearance of lipoma arborescens on all imaging modalities. In addition, on ultrasonography, lipoma arborescens may have a wave-like motion within an intra-articular effusion. (14) Another extremely rare differential diagnosis is intra-articular angiomyolipoma, which has only one reported case in literature. This lesion was discovered in the knee, superior to the Hoffa's fat pad, and only part of the angiomyolipoma had MR imaging signal that was isointense to fat. The rest of the lesion had heterogeneous signal intensity and contained areas of fluid-like signal. (18) Depending on its size, intra-articular lipoma can be resected arthroscopically or via open surgery. (14) (15) (16) 
CONCLUSION
With the advent of advanced imaging techniques, asymptomatic, benign periarticular, bone and joint lipomatous lesions are increasingly discovered incidentally. Awareness of the imaging characteristics of these lesions at various sites of the body and on different modalities is useful. It can prevent unnecessary biopsies in the absence of aggressive features, which helps to optimise clinical management. 
